PCMA President Mark Merritt: Drugmakers want high prices; PBMs want low prices | Watch PCMA president and CEO on CNBC's "Closing Bell" | New PCMA study: No link between rebates, high drug prices
April 20, 2017
PCMA SmartBrief
News for the PBM Industry
Featured Stories
PCMA President Mark Merritt: Drugmakers want high prices; PBMs want low prices
Mark Merritt
Drugmakers are sellers that want prices to be as high as possible, while pharmacy benefit manager are buyers representing clients that want prices as low as possible, PCMA President and CEO Mark Merritt says in this CNBC interview.
CNBC (4/19) 
LinkedIn Twitter Facebook Google+ Email
New PCMA study: No link between rebates, high drug prices
A newly released study shows no correlation between high drug prices and rebates paid by drugmakers to pharmacy benefit managers.
CNBC (4/19) 
LinkedIn Twitter Facebook Google+ Email
Legislative & Regulatory News
GOP finalizing health care legislation, Ryan says
GOP finalizing health care legislation, Ryan says
Ryan (Zach Gibson/Getty Images)
Republican lawmakers are negotiating "finishing touches" on the revived health care legislation that would unravel portions of the Affordable Care Act, House Speaker Paul Ryan, R-Wis., said Wednesday.
The Hill (4/19) 
LinkedIn Twitter Facebook Google+ Email
Payers mostly in for 2018, but caution around ACA markets abounds, survey finds
Payers mostly in for 2018, but caution around ACA markets abounds, survey finds.
(Joe Raedle/Getty Images)
A survey conducted earlier this month by Oliver Wyman found 96% of payers intend to remain in the Affordable Care Act market, 75% plan to retain their existing geographic footprint and 71% have no plans to change their current offerings. However, the authors note payers could change their plans at any time, and about half said it was too early to determine whether and by how much premiums will rise.
MedCityNews.com (4/19) 
LinkedIn Twitter Facebook Google+ Email
Drug Industry Spotlight
AbbVie's experimental PARP inhibitor fails in 2 trials
AbbVie's experimental drug veliparib failed to meet primary goals in a late-stage clinical trial for non-small cell lung cancer and another for triple-negative breast cancer, according to the drugmaker. Veliparib is designed to block enzymes involved in DNA repair of cancer cells.
Reuters (4/19) 
LinkedIn Twitter Facebook Google+ Email
DOJ seeks info from Pfizer on saline shortages
The Department of Justice issued subpoenas to Pfizer in an ongoing investigation into the saline market, which has been plagued by shortages since 2013. ICU Medical, which acquired Hospira Infusion Systems in February, also received a subpoena.
Modern Healthcare (tiered subscription model) (4/19) 
LinkedIn Twitter Facebook Google+ Email
Opinion, Commentary & Analysis
Commentary: PBMs have negotiating muscle the government lacks
The pharmacy benefit managers that handle Medicare Part D plans not only "have massive buying power," they also have the ability to refuse to pay for a given drug if a more cost-efficient product exists, writes Devon Herrick. On the other hand, the federal government "lacks the willpower to say no in the face of angry seniors convinced they need a drug they heard about on TV," Herrick writes.
National Center for Policy Analysis (4/19) 
LinkedIn Twitter Facebook Google+ Email
Medicare Part D Infographic
Tweet from @pcma.net: MT @devonherrick: #Medicare drug plans have cost taxpayers less than projected b/c of competition. @NCPA @pcmanet
LinkedIn Twitter Facebook Google+ Email
Money doesn't change men. It merely unmasks them.
Henry Ford,
LinkedIn Twitter Facebook Google+ Email
Learn more about PCMA:
Upcoming PCMA Events | PCMA Newsroom
Become a PCMA Affiliate
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 266 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

Contact PCMA
Charles Cote
Vice President, Strategic Communications
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information